In the growing GLP-1 space, Rousselot highlights how its collagen peptides support consumers in two market segments, either in complementing the medication or as natural boosters of metabolic wellness. Lauretta Katsriku, global category leader of Collagen at Rousselot, tells Nutrition Insight that GLP-1 medications are fundamentally changing how people eat and interact with nutrition as they are “here to stay.”
